22 related articles for article (PubMed ID: 10212133)
1. The possible separation of 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation and hyperplasia by compound A.
Kowalczyk P; Kowalczyk MC; Junco JJ; Tolstykh O; Kinjo T; Truong H; Walaszek Z; Hanausek M; Slaga TJ
Mol Carcinog; 2013 Jun; 52(6):488-96. PubMed ID: 22351517
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling on structure-function analysis of human progesterone receptor modulators.
Pal R; Islam MA; Hossain T; Saha A
Sci Pharm; 2011; 79(3):461-77. PubMed ID: 21886897
[TBL] [Abstract][Full Text] [Related]
3. 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.
Zhi L; Tegley CM; Kallel EA; Marschke KB; Mais DE; Gottardis MM; Jones TK
J Med Chem; 1998 Jan; 41(3):291-302. PubMed ID: 9464360
[TBL] [Abstract][Full Text] [Related]
4. 5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.
Tegley CM; Zhi L; Marschke KB; Gottardis MM; Yang Q; Jones TK
J Med Chem; 1998 Oct; 41(22):4354-9. PubMed ID: 9784110
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
Dong Y; Roberge JY; Wang Z; Wang X; Tamasi J; Dell V; Golla R; Corte JR; Liu Y; Fang T; Anthony MN; Schnur DM; Agler ML; Dickson JK; Lawrence RM; Prack MM; Seethala R; Feyen JH
Steroids; 2004 Mar; 69(3):201-17. PubMed ID: 15072922
[TBL] [Abstract][Full Text] [Related]
6. 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.
Edwards JP; West SJ; Marschke KB; Mais DE; Gottardis MM; Jones TK
J Med Chem; 1998 Jan; 41(3):303-10. PubMed ID: 9464361
[TBL] [Abstract][Full Text] [Related]
7. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.
Higuchi RI; Arienti KL; López FJ; Mani NS; Mais DE; Caferro TR; Long YO; Jones TK; Edwards JP; Zhi L; Schrader WT; Negro-Vilar A; Marschke KB
J Med Chem; 2007 May; 50(10):2486-96. PubMed ID: 17439112
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal progesterone receptor modulators: structure activity relationships.
Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal progesterone receptor specific ligands.
Allan GF; Sui Z
Mini Rev Med Chem; 2005 Aug; 5(8):701-8. PubMed ID: 16101406
[TBL] [Abstract][Full Text] [Related]
10. Discovery of structurally diverse nonsteroidal SPRMs based on a screening hit, 1,2-dihydro-2,2,4-trimethyl-6-phenylquinolinone.
Zhi L
Curr Top Med Chem; 2008; 8(9):766-80. PubMed ID: 18537687
[TBL] [Abstract][Full Text] [Related]
11. 5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-ring modification.
Zhi L; Tegley CM; Marschke KB; Mais DE; Jones TK
J Med Chem; 1999 Apr; 42(8):1466-72. PubMed ID: 10212133
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
